Core Viewpoint - The document outlines the investor relations management guidelines for Shanghai Fosun Pharmaceutical (Group) Co., Ltd., emphasizing the importance of effective communication with investors, particularly small and medium-sized investors, to enhance corporate governance and overall value [1][2]. Group 1: Principles of Investor Relations Management - Compliance Principle: Investor relations management must adhere to legal and regulatory requirements, ensuring transparency and ethical conduct [2]. - Equality Principle: All investors should be treated equally, with special provisions for small and medium-sized investors to participate [2]. - Proactivity Principle: The company should actively engage with investors, listening to their feedback and addressing their concerns promptly [2]. - Honesty and Integrity Principle: The company must maintain integrity and responsibility in its investor relations activities, fostering a healthy market environment [2]. Group 2: Responsibilities and Organization - Responsibilities: The company is tasked with drafting detailed investor relations management guidelines, organizing communication activities, handling investor inquiries and complaints, and maintaining relevant channels and platforms [5][6]. - Management Structure: The board of directors is responsible for decision-making in investor relations, with the chairman overseeing daily management through a designated department [3][4]. Group 3: Communication Content and Methods - Communication Content: The company should communicate information related to its development strategy, legal disclosures, operational management, environmental, social, and governance (ESG) information, and shareholder rights [8]. - Communication Channels: The company is encouraged to utilize multiple channels such as its official website, new media platforms, and direct communication methods like investor meetings and roadshows to engage with investors [5][6]. Group 4: Investor Meetings and Events - Investor Meetings: The company must hold investor meetings, including performance briefings and special sessions for significant events, ensuring that key personnel are present to address investor inquiries [10][11]. - Documentation: The company should maintain records of investor relations activities, including participant details, communication content, and any materials used during these events [12].
复星医药: 复星医药投资者关系管理办法(2025年修订)